简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
159839.SZ
China Universal CNI BIOMEDICINE ETF (159839) last quoted at RMB 0.39, with the latest margin buying of RMB 6.3803 million
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-08-21
China Universal CNI BIOMEDICINE ETF (159839) last traded at RMB 0.41, with margin net buying of RMB 4.4087 million on the previous trading day
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-08-20
China Universal CNI BIOMEDICINE ETF (159839) rises 2.79%, with the latest margin financing purchase amount reaching 6.7191 million yuan
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-07-15
China Universal CNI BIOMEDICINE ETF(159839) rises 0.97%, aiming for a third consecutive gain
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-06-23
China Universal CNI BIOMEDICINE ETF(159839) Falls 0.83%, Sees Net Inflow of 25.3434 Million Yuan Over the Past 10 Trading Days
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-04-30
China Universal CNI BIOMEDICINE ETF(159839) Falls 1.10%, Absorbs 15.4519 Million Yuan Over the Past 10 Trading Days
Tags:
ETF
159839.SZ
China Universal CNI BIOMEDICINE ETF
2026-04-29
Differentiation in the Innovative Drug Sector Accelerates Further,China Universal CNI BIOMEDICINE ETF(159839) Rises 1.43% Intraday
Tags:
ETF
China Universal CNI BIOMEDICINE ETF
159839.SZ
2026-03-31
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App